Articles mentioning Ligand Pharmaceuticals (LGND)

Results 11 - 20 of 20 : Previous 1 2

Get RSS Feed for LGND

High-Growth Investing | November 24, 2008

Is Amgen's Nplate a Blockbuster?

Amgen gets a positive recommendation from European officials.

High-Growth Investing | November 21, 2008

Ligand and Glaxo Like the FDA's Answer

Good news arrives for blood-clot buster Promacta.

Investing | November 07, 2008

Unloved Stocks Ready to Shine

See what the best CAPS players recommend now.

Investing | October 31, 2008

Will These Delayed Drugs Make It to Market?

The FDA is taking its own sweet time.

High-Growth Investing | October 24, 2008

Amgen's Back

Growth from the big biotech returns.

Dividends & Income Investing | September 10, 2008

A Pfizer Drug With a Cloudy Future

The company offers another drug with mixed odds to the FDA.

High-Growth Investing | August 25, 2008

Amgen Gets Its FDA Response

And it's a good one for a change.

High-Growth Investing | July 21, 2008

Amgen Rolls the Dice

The Food and Drug Administration's impending ruling will determine the drugmaker's near-term fate.

High-Growth Investing | June 23, 2008

Wait a Little Longer, Ligand

The FDA delays its review of blood-disorder drug Promacta.

Investing | April 04, 2007

Companies That Pay Out ... and Drop

An explanation of why a stock price falls after a large one-time dividend payout.

Results 11 - 20 of 20 : Previous 1 2

Get RSS Feed for LGND